Presentation TCT 2024 How Can Clinical Trials Mobilize the Diversity Efforts? Presenter: Roxana Mehran October 29, 2024
Presentation TCT 2023 Implications for RCTs and Work Force Considerations Presenter: Roxana Mehran October 24, 2023
Presentation TCT 2019 Guideline Requirement for Diagnostic Devices Presenter: Roxana Mehran September 25, 2019
Presentation TCT 2018 Patient Perspectives on Sham-Controlled Trials Presenter: Kenneth J. Cavanaugh Jr, Roxana Mehran, Debbe McCall September 23, 2018
Presentation TCT 2018 FDA Perspectives on Sham-Controlled Trials Presenter: Kenneth J. Cavanaugh Jr, Roxana Mehran, Hiren Mistry September 23, 2018
Presentation TCT 2018 Sham Controls in Renal Denervation Studies: Need to Have vs Nice to Have? Presenter: Kenneth J. Cavanaugh Jr, Roxana Mehran, David E. Kandzari September 23, 2018
Presentation TCT 2018 ORBITA One Year Later: What Would I Do Differently, If Anything? Presenter: Kenneth J. Cavanaugh Jr, Roxana Mehran, Rasha Al-Lamee September 23, 2018
Presentation TCT 2017 Strategies to Increase Enrollment of Women and Minorities Into Clinical Trials Presenter: David P. Faxon, Cindy L. Grines, Roxana Mehran October 31, 2017
Presentation TCT 2017 Featured Lecture: The NIH Mission to Enhance DIVERSITY in Clinical Trials, Education, and the Workforce Presenter: Roxana Mehran, George A. Mensah October 31, 2017
Presentation TCT 2017 Featured Lecture: Disparities Among Healthcare Providers and Optimal Cardiovascular Care Pathways in Underserved Populations - Realities and Solutions Presenter: Roxana Mehran, George A. Mensah, Cheryl Pegus October 31, 2017
Presentation TCT 2017 Diversity in Clinical Trials (Lessons Learned, Future Directions): Inclusion of Women Presenter: Wayne B. Batchelor, George A. Mensah, Roxana Mehran October 30, 2017
Presentation TCT 2014 Innovative Technologies to Reduce and Monitor Contrast Dosage During Angiography Presenter: Chaim S. Lotan, Julio C. Palmaz, Mark A. Turco, Roxana Mehran September 15, 2014
Presentation TCT 2014 Statistical and Regulatory Challenges with Big Data and National Registries: Is Propensity Adjustment Enough? FDA Considerations Presenter: Matthew G. Hillebrenner, Roxana Mehran, Aaron V. Kaplan, Gregory Campbell September 15, 2014
Presentation TCT 2014 Are We Ready for Radical Changes in Medical Device Clinical Trial Designs? Presenter: Matthew G. Hillebrenner, Roxana Mehran, Aaron V. Kaplan, Robert M. Califf September 15, 2014
Presentation TCT 2014 CDRH Efforts to Improve the Ecosystem for Clinical Trials Presenter: Matthew G. Hillebrenner, Roxana Mehran, Aaron V. Kaplan, Owen Faris September 15, 2014
Presentation TCT 2014 Keynote Lecture II: Clinical Research in the United States Current Realities and How the Tide Can Turn Presenter: Matthew G. Hillebrenner, Roxana Mehran, Aaron V. Kaplan, Robert A. Harrington September 15, 2014
Presentation TCT 2014 The Informed Consent Process: More Complicated Than Informed! Presenter: Roxana Mehran, Bernhard Witzenbichler, Somjot S. Brar, Theresa Franklin-Bond September 13, 2014